Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: Mycobacterium avium complex (MAC) pulmonary infection was previously associated with gastroesophageal reflux disease (GERD), although the effects of GERD on MAC outcomes remains unclear. The goal of this study was to assess the prevalence of GERD in patients with MAC pulmonary infection and its association with clinical outcomes.
Methods: This was a retrospective study of adult patients with confirmed MAC pulmonary infection who underwent ambulatory pH monitoring. Pathologic acid reflux was defined as a total distal acid exposure time ≥6 %. Adjunctive esophageal tests including esophagogastroduodenoscopy, barium esophagram, and high-resolution manometry were assessed. The primary outcomes were pulmonary function testing and treatment of MAC pulmonary infection.
Results: Of 132 included patients, 35 (26.5 %) had an acid exposure time ≥6 %. There were no differences between patients with and without pathologic acid reflux by AET and pulmonary function tests including FEV1 absolute (1.79 vs. 1.83 L, p = 0.68), FEV1 % predicted (78.6 vs. 78.0 %, p = 0.94), FEV1/FVC % predicted (71.1 vs. 68.0 %, p = 0.38), or DLCO % predicted (66.0 vs. 79.0 %, p = 0.097). Additionally, there were no differences in MAC pulmonary infection outcomes including antimicrobial treatment, duration, or lobectomy. Findings on adjunctive esophageal testing did not associate with outcomes by pulmonary function tests or treatment of MAC pulmonary infection.
Conclusions: The prevalence of GERD in patients with MAC pulmonary infection based on ambulatory pH monitoring was 26.5 %. MAC pulmonary infection with GERD was not associated with worse outcomes and further study is needed to assess the impacts of GERD on MAC pulmonary infection.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.resinv.2025.05.006 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Early diagnosis and favorable outcomes of pulmonary Mycobacterium avium complex disease diagnosed by gastric aspirate culture.
Respir Investig
August 2025
Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, 6-16-1 Tomiokahigashi, Kanazawa-ku, Yokohama, Kanagawa, 236-0051, Japan.
Background: Diagnosing pulmonary Mycobacterium avium complex (MAC) disease in asymptomatic patients is challenging due to difficulty in collecting sputum culture. This study evaluated the clinical and characteristics and outcomes of patients diagnosed through gastric aspirate culture to assess its usefulness.
Methods: We retrospectively analyzed 125 patients with radiological findings consistent with pulmonary MAC disease who had positive MAC cultures from gastric aspirate between April 2014 and March 2022.
Direct detection and rapid speciation and subspeciation of Mycobacterium avium complex using five-target multiplex PCR and clinical correlations in HIV-positive patients in Tehran, Iran.
Diagn Microbiol Infect Dis
December 2025
Department of Infectious Diseases and Tropical Medicine, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
Disseminated Mycobacterium avium complex (DMAC) infection is a major AIDS-defining condition with diagnostic challenges due to nonspecific symptoms. This study, for the first time in Iran, aimed to discriminate MAC organisms in 100 HIV-positive patients directly from clinical specimens and assess their clinical significance, epidemiological characteristics, and associated risk factors through a detailed review of medical and demographic records. Clinical specimens (blood, sputum, and stool) were collected, and routine clinical evaluations were performed.
View Article and Find Full Text PDFImproved efficiency of the new Mirus™ system challenged by ventilatory settings-a bench study.
J Clin Monit Comput
August 2025
Department of Anesthesiology, Intensive Care and Pain Therapy, Saarland University Medical Center and Saarland University Faculty of Medicine, Homburg, Germany.
The Mirus™ system (Technologie Institut Medizin GmbH, Germany) enables target-controlled delivery of volatile anaesthetics with open system ventilators. Its interface, positioned between Y-piece and the patient, injects anaesthetic vapor during inspiration, while adsorbing anaesthetic and resupplying it during the next inspiration. A newly introduced interface (Lisa-44) was evaluated under body temperature pressure saturated and normocapnic conditions using a test lung.
View Article and Find Full Text PDFAssociation of T-cell immunoglobulin and mucin domain-3 gene polymorphism with susceptibility and severity of Mycobacterium avium complex lung disease: a prospective study in Taiwan.
Int J Infect Dis
August 2025
Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; College of Medicine, National Taiwan University, Taipei, Taiwan.
Objectives: Patients with Mycobacterium avium complex lung disease (MAC-LD) may exhibit immune exhaustion, characterized by elevated T-cell immunoglobulin and mucin domain-3 (TIM3) protein expression on T lymphocytes. Whether single-nucleotide polymorphisms in TIM3 genes are associated with susceptibility to MAC-LD and its clinical presentation remains unknown.
Methods: Patients with MAC-LD and controls were recruited to assess associations between three TIM3 gene single-nucleotide polymorphisms and MAC-LD susceptibility and severity.
Genetic and epigenetic dysregulation of CR1 is associated with catastrophic antiphospholipid syndrome.
Ann Rheum Dis
August 2025
Division of Hematology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA. Electronic address:
Objectives: Catastrophic antiphospholipid syndrome (CAPS) is a complement-driven thrombotic disorder, characterised by widespread thrombosis and multiorgan failure. We identified rare germline variants including complement receptor 1 (CR1) in 50% of patients with CAPS. Here, we define CR1 dysregulation mechanisms (genetic/epigenetic) underlying complement-mediated thrombosis in CAPS and support C5 inhibition as a potential therapy.
View Article and Find Full Text PDF